- Home
- XPEV vs NTRA Comparison
XPEV vs NTRA Comparison
Compare XPEV & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEV
- NTRA
- Stock Information
- Founded
- XPEV 2015
- NTRA 2003
- Country
- XPEV China
- NTRA United States
- Employees
- XPEV N/A
- NTRA N/A
- Industry
- XPEV Auto Manufacturing
- NTRA Medical Specialities
- Sector
- XPEV Consumer Discretionary
- NTRA Health Care
- Exchange
- XPEV Nasdaq
- NTRA Nasdaq
- Market Cap
- XPEV 21.7B
- NTRA 24.9B
- IPO Year
- XPEV 2020
- NTRA 2015
- Fundamental
- Price
- XPEV $21.19
- NTRA $181.29
- Analyst Decision
- XPEV Buy
- NTRA Strong Buy
- Analyst Count
- XPEV 8
- NTRA 17
- Target Price
- XPEV $22.51
- NTRA $192.71
- AVG Volume (30 Days)
- XPEV 7.7M
- NTRA 1.2M
- Earning Date
- XPEV 11-18-2025
- NTRA 11-11-2025
- Dividend Yield
- XPEV N/A
- NTRA N/A
- EPS Growth
- XPEV N/A
- NTRA N/A
- EPS
- XPEV N/A
- NTRA N/A
- Revenue
- XPEV $8,416,181,216.00
- NTRA $1,964,250,000.00
- Revenue This Year
- XPEV $99.57
- NTRA $24.28
- Revenue Next Year
- XPEV $39.79
- NTRA $15.50
- P/E Ratio
- XPEV N/A
- NTRA N/A
- Revenue Growth
- XPEV 66.37
- NTRA 44.38
- 52 Week Low
- XPEV $10.07
- NTRA $117.27
- 52 Week High
- XPEV $27.16
- NTRA $187.34
- Technical
- Relative Strength Index (RSI)
- XPEV 44.34
- NTRA 66.20
- Support Level
- XPEV $20.81
- NTRA $167.99
- Resistance Level
- XPEV $22.13
- NTRA $187.34
- Average True Range (ATR)
- XPEV 0.81
- NTRA 5.64
- MACD
- XPEV -0.29
- NTRA 1.14
- Stochastic Oscillator
- XPEV 11.94
- NTRA 79.78
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.